NCT03837119已完成不适用
Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies
University Hospital, Basel, Switzerland2 个研究点 分布在 1 个国家目标入组 540 人开始时间: 2018年4月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 540
- 试验地点
- 2
- 主要终点
- cholestasis in pregnancy
研究概览
简要总结
This retrospective study aims to investigate pregnancy outcome in women with heterozygous hemoglobinopathies (regarding gestational diabetes, cholestasis and urinary tract infections) and to analyze if there are aggravated maternal and/or perinatal risks.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •pregnant women with or without heterozygous hemoglobinopathy
排除标准
- •refusal of study participation
结局指标
主要结局
cholestasis in pregnancy
时间窗: in the course of pregnancy until delivery
number of women developing cholestasis in pregnancy
urinary tract infection
时间窗: in the course of pregnancy until delivery
number of women developing urinary tract infection
gestational diabetes
时间窗: in the course of pregnancy until delivery
number of women developing gestational diabetes in pregnancy
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
Effect of Different Maternal Hemoglobin and Hematocrit Values on Perinatal OutcomeHemoglobin and Hematocrit Values on Perinatal OutcomeNCT06726915Ali Mohamed Mohamed Ammar403
招募中
4 期
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency AnemiaAnemia, Iron DeficiencyPregnancy AnemiaNCT06061393Western Galilee Hospital-Nahariya200
进行中（未招募）
不适用
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During PregnancyMigraineNCT05198245Pfizer1
已完成
不适用
Pregnancy and Fibrinogen DisordersHypofibrinogenemia, CongenitalAfibrinogenemia, CongenitalDysfibrinogenemia, CongenitalNCT03920332University Hospital, Geneva149
已完成
不适用
Screening for Hemoglobinopathies in Pregnant WomenHemoglobinopathiesNCT04029142University Hospital, Basel, Switzerland1,785